Beyond Weight Loss, Semaglutide Unexpectedly Linked to Lower Fracture Risk
A real-world analysis of nearly 60,000 adults with type 2 diabetes extends the discussion of GLP-1 drugs from weight and blood glucose to bone; the signal is intriguing, but it cannot yet be read as a bone-protecting prescription.